VHV. P. Hreniukh

V. P. Hreniukh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


V. P. Hreniukh has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of thiazole derivative complexed with nanoscale polymeric carriers on cellular ultrastructure of murine lymphoma cells in vivo

    by M. V. Popovych, Ya. R. Shalai, V. P. Hreniukh, O. R. Kulachkovskyy, S. M. Mandzynets, N. E. Mitina, O. S. Zaichenko, A. M. Babsky

    Background. A pronounced cytotoxic action of the thiazole derivatives complexed with polymeric carriers on tumor cells in vitro was reported earlier, while no cytotoxicity of these compounds was detected toward noncancerous cells. It was found that thiazole derivatives at concentrations of 10 and 50 µM affected lymphoma cell ultrastructure in vitro. The purpose of this work was to investigate the effect of thiazole derivative 8-methyl-2-Me-7-[trifluoromethyl-phenylmethyl]-pyrazolo-[4,3-e]-[1,3]- thiazolo-[3,2-a]-pyrimidin-4(2H)-one (PP2) and its complexes with polymeric carriers poly(VEP-co-GMA)-graft-mPEG (Th12) and poly(PEGMA) (Th14) on the ultrastructure of lymphoma cells in vivo. Materials and Methods. Experiments were conducted on white wild-type male mice with grafted NK/Ly lymphoma. Ascite tumors were created by intreperitoneal inocu­lation of 1–2 mln of Nemet–Kelner lymphoma cells to mice. On the 12th day after inoculation, the body weight of animals was increased by 140–160 % mostly due to ascites growth. For treatment of ascites three solutions of the chemical compounds were prepared: PP2, PP2 + Th12, PP2 + Th14 and administered to the mice intraperitoneally for 5 days. The final concentration of PP2 was 5 mg/kg of body weight. Abdominal drainage from ascites was performed with a sterile syringe under chloroform anesthesia on the 10th day after the start of treatment. The ultrastructure of the cells was examined by electron microscopy. Results. Еlectron microscopy study showed that control lymphoma cells have a special subcellular formations such as a relatively large nucleus, and specific plasma membrane filaments. The effects of thiazole derivative revealed apoptotic and necrotic manifestations of cytotoxicity, such as a deformation and disintegration of nucleus, a decreased nucleus/cytoplasm ratio, a destruction of the plasma membrane and a change of mitochondria shape. The studied compound complexed with polymeric carriers caused an apoptotic-like changes in lymphoma cells. Under the action of such complexes, the nucleus/cytoplasm ratio decreased and the area of mitochondria increased. Conclusions. The obtained results suggest that the tested compounds induce apoptosis in tumor cells. Complexes of thiazole derivative with polymers do not impair the effect of the compound on lymphoma cells. The obtained data can be used to carry out further preclinical studies of thiazole derivatives complexed with polymeric carriers as potential antitumor drugs.


  • Prooxidant and antioxidant processes in lymphoma cells under the action of pyrazolopyrimidine derivative

    by Ya. R. Shalai, M. V. Popovych, S. M. Mandzynets, V. P. Hreniukh, N. S. Finiuk, A. M. Babsky

    Background. The influence in vitro of thiazole derivative 8-methyl-2-Me-7-[trifluoro­methyl-phenylmethyl]-pyrazolo-[4,3-e]-[1,3]-thiazolo-[3,2-a]-pyrimidin-4(2H)-one (PP2) on the level of lipid peroxidation products, superoxide anion radical and antioxidant system activity in lymphoma cells was studied. A pronounced cytotoxic action of the thiazole derivative on the tumor cells in vitro was reported earlier, however, no cytotoxicity of this substance was detected toward non-cancerous cells. In addition, it was shown that the sca­vengers of active forms of Oxygen significantly reduced the cytotoxic effect of the studied compound. The purpose of this work was to investigate the effect of 8-methyl-2-Me-7-[trifluoromethyl-phenylmethyl]-pyrazolo-[4,3-e]-[1,3]-thiazolo-[3,2-a]-pyrimidin-4(2H)-one on the content of lipid peroxidation products, superoxide radical and the activity of enzymes of antioxidant defense in the lymphoma cells. Materials and Methods. Experiments were conducted on white wild-type male mice with grafted NK/Ly lymphoma. Ascites tumor cells were passaged by the intreperitoneal inoculation to mice. Abdominal drainage with ascites was performed with a sterile syringe under ether anesthesia. PP2 was dissolved in dimethylsulfoxide. The product content and enzymatic activity were determined spectrophotometrically. Statistical analysis of obtained results was carried out using MS Excel-2013 program. Results. The influence of the pyrazolopyrimidine derivative on the content of lipid peroxidation products and superoxide radical in lymphoma cells was investigated. It was found that the studied compound did not change the amount of the primary lipid peroxidation products, but reduced the amount of secondary products. A decrease in the MDA content under the action of the studied derivative indicates probable interaction of the substance with the reactive Oxygen species. Pyrazolopyrimidine derivative did not change the level of the superoxide radical. The effect of the thiazole derivative on the activity of key enzymes of the antioxidant system in lymphoma cells was investigated. The studied compound at the concentration of 10 µM activated superoxide dismutase. Pyrazolopyrimidine derivative decreased the activity of catalase and glutathione peroxidase. Such changes in the activity of enzymes can cause the growth of hydrogen peroxide in the cell, which is toxic in large quantities. Conclusions. The obtained results may indicate that the studied pyrazolopyrimidine derivative can realize its cytotoxic effect on lymphoma cells though the action on the pro­ducts of lipid peroxidation and antioxidant system activity. These data can be used to understand the mechanism of action of the studied compounds and for further improvement of their antitumor effect. Keywords: lymphoma, pyrazolopyrimidine derivative, lipid peroxidation, antioxidant system, antitumor drugs


  • Open Access

    Effect of novel 2-amino-5-benzylthiazole derivative on cellular ultrastructure and activity of antioxidant system in murine lymphoma cells

    by Ya. R. Shalai, M. V. Popovych, O. R. Kulachkovskyy, V. P. Hreniukh, S. M. Mandzynets, N. S. Finiuk, A. M. Babsky

    Biol. Stud. 2019: 13(1); 51–60 • DOI: https://doi.org/10.30970/sbi.1301.591 EFFECT OF NOVEL 2-AMINO-5-BENZYLTHIAZOLE DERIVATIVE ON CELLULAR ULTRASTRUCTURE AND ACTIVITY OF ANTIOXIDANT SYSTEM IN MURINE LYMPHOMA CELLS


  • Open Access

    Evaluation of antiproliferative activity of pyrazolothiazolopyrimidine derivatives

    by N. S. Finiuk, Yu. V. Ostapiuk, V. P. Hreniukh, Ya. R. Shalai, V. S. Matiychuk, M. D. Obushak, R.S. Stoika, A. M. Babsky


  • Open Access

    Effects of new derivatives of 2-amino-5-benzylthiazole of genotoxicity and acute toxicity in Allium bioassays

    by N. S. Finiuk, V. P. Hreniukh, Yu. V. Ostapiuk, V. S. Matiychuk, M. D. Obushak, R. S. Stoika, A. M. Babsky

    Biol. Stud. 2018: 12(2); 25–34 • DOI: https://doi.org/10.30970/sbi.1202.568 EFFECTS OF NEW DERIVATIVES OF 2-AMINO-5-BENZYLTHIAZOLE ON GENOTOXICITY AND ACUTE TOXICITY IN ALLIUM BIOASSAY


  • Open Access

    Processes of lipopero­xidation and respiration of mitochondria in rat liver under the action of thiazoles derivatives in vitro

    by Ya. R. Shalai, S. M. Mandzynets, N. S. Finiuk, V. P. Hreniukh, A. M. Babsky

    Biol. Stud. 2018: 12(2); 35–44 • DOI: https://doi.org/10.30970/sbi.1202.551 PROCESSES OF LIPOPEROXIDATION AND RESPIRATION OF MITOCHONDRIA IN RAT LIVER UNDER THE ACTION OF THIAZOLES DERIVATIVES IN VITRO

  • Effect of bafilomycin and NAADP on membrane‐associated ATPases and respiration of isolated mitochondria of the murine Nemeth‐Kellner lymphoma

    by V. Hreniukh, S. Bychkova, O. Kulachkovsky, A. Babsky

    The goal of the study was to estimate the effect of a selective V‐type H+‐ATPase inhibitor bafilomycin A1 and nicotinic acid adenine dinucleotide phosphate (NAADP) on energetic processes in NK/Ly cell by directly measuring the respiration of isolated mitochondria and ATPase activities.NAADP (7 μM) increased the activity of Na+/K+‐ATPase in the postmitochondrial fraction of NK/Ly cells, but lower concentration of NAADP decreased it (0.1 and 1 μM). The increase the activity of plasma membrane Ca2+ ATPase (PMCA) under NAADP application (1 and 7 μM) was observed. However, NAADP (1 μM) decreased activities of sarcoendoplasmic reticulum Ca2+‐ATPase (SERCA) and basal Mg2+‐ATPase. Bafilomycin A1 (1 μM) increased the activity of Na+/K+‐ATPase and potentiated the effect of NAADP (1 μM) on this pump. At the same time, bafilomycin A1 (1 μM) completely prevented all effects of NAADP (1 μM) on activities of PMCA, SERCA, and basal Mg2+‐ATPase, confirming that these effects are dependent on acidic stores.Bafilomycin A1 or NAADP decreased respiratory and oxidative phosphorylation rates in NK/Ly mitochondria when α‐ketoglutarate was used as substrate in contrast to succinate. Thus, α‐ketoglutarate oxidation is more sensitive to bafilomycin A1 and NAADP influences compared with succinate oxidation. However, bafilomycin A1 + NAADP and any of these compounds separately lead to full uncoupling of mitochondria after ADP addition irrespectively to substrate used. Bafilomycin A1 affects isolated tumor mitochondria more effectively in combination with NAADP. Bafilomycin and NAADP alter some membrane‐associated ATPases and inhibit respiration in mitochondria of the Nemeth‐Kellner lymphoma.Significance of research paragraph: Bafilomycin A1 potentiates the effect of NAADP by inhibiting the mitochondrial energetic process in lymphoma cells and activity of Na+/K+‐ATPase. The obtained data show promising possibility to use bafilomycin A1 and NAADP as chemotherapeutic agents for lymphoma cells treatment. This is important because lymphomas are seventh most common form of cancer. Today the lymphoma mortality is 15% to 30%, whereas the effectiveness of malignant neoplasms treatment is less than 50%.